Intra- and Inter-Market Trade-Offs Pharma companies must consider the impact of an OOP strategy for obesity in markets where both reimbursed and non-reimbursed channels exist, especially for reimbursable indications like Type 2 Diabetes treated by the same molecule under different brands (e.g., Wegovy vs Ozempic) or the same brand (e.g., Mounjaro in Europe)
Diagnosis of NCGS can be difficult because of the lack of reliable biomarkers, and the symptoms can be nontypical
Boza JJ, Moennoz D, Bournot CE, Blum S, Zbinden I, Finot PA, Ballevre O
Yes, taurine, carnitine, and potassium support energy metabolism and muscle contraction
Doxorubicin and organosilicon nanoparticles-niosomes- based pharmaceutical gel for skin cancer treating